文献速递胸部肿瘤

联合分析侵袭边缘与肿瘤中心评估旁观者CD8+ T细胞在早期非小细胞肺癌中的预后价值

[Joint analysis of invasive margins and tumor center to evaluate the prognostic value of bystander CD8+ T cells in early-stage non-small cell lung cancer].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2025-01-01

本研究回顾性收集173例ⅠA~ⅡA期非小细胞肺癌根治术后标本,用多色免疫荧光检测侵袭边缘(IM)与肿瘤中心(TC)的CD8+ T细胞及旁观者CD8+ T细胞(CD8+ Tbys)密度。IM区两种细胞密度均高于TC;IM CD8+ T低密度为术后复发独立危险因素(HR=1.836),IM CD8+ Tbys低密度伴TC CD8+ Tbys高密度组RFS显著降低且为独立风险因素(HR=2.090)。

要点

  • IM区CD8+ T与CD8+ Tbys密度均显著高于TC区。
  • IM CD8+ T低密度是术后复发独立危险因素(HR=1.836)。
  • IM CD8+ Tbys低密度伴TC CD8+ Tbys高密度者RFS显著降低(HR=2.090)。

核心结论

  • CD8+ Tbys在原发灶的空间分布影响早期NSCLC患者预后,IM CD8+ Tbys低密度伴TC CD8+ Tbys高密度的患者根治术后易复发。

研究设计与样本

  • 回顾性收集2014—2018年山东第一医科大学附属肿瘤医院173例原发性早期NSCLC根治术后标本,制备IM和TC区域组织微阵列。
  • 采用多色免疫荧光染色(CK/CD8/CD103/DAPI),inFrom软件识别表型,R语言自动定量细胞千分密度。

主要发现

  • 共纳入173例ⅠA~ⅡA期NSCLC患者,中位随访67.8个月(58.4~79.4个月),复发率26.6%(46/173),中位RFS 62.3个月(44.7~71.9个月)。
  • IM区CD8+ T密度高于TC区[70(32,155)个 vs 37(18,88)个,P<0.001];IM区CD8+ Tbys密度高于TC区[25(11,46)个 vs 18(7,34)个,P=0.002]。
  • CD8+ T、CD8+ Tbys与年龄、性别、吸烟史、组织学类型及病理分期均无关(均P>0.05)。
  • IM CD8+ T低密度组较IM CD8+ T高密度组RFS更低(中位RFS均未达到,P=0.021);IM CD8+ Tbys低密度组较IM CD8+ Tbys高密度组RFS更低(中位RFS均未达到,P=0.047)。
  • IM CD8+ Tbys低密度伴TC CD8+ Tbys高密度组较其他3组RFS显著降低(P=0.006)。

关键数值与推荐

  • IM CD8+ T低密度为术后复发独立危险因素(HR=1.836,95% CI:1.007~3.347,P=0.048)。
  • IM CD8+ Tbys低密度伴TC CD8+ Tbys高密度为早期NSCLC术后复发独立风险因素(HR=2.090,95% CI:1.162~3.760,P=0.014)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: The impact of bystander CD8+ T cells (CD8+ Tbys) within the tumor microenvironment on the prognosis of early-stage non-small cell lung cancer (NSCLC) remains unclear, particularly concerning their infiltration differences at the invasive margin (IM) and tumor center (TC). Methods: We retrospectively collected postoperative specimens from 173 patients with primary early-stage NSCLC who underwent radical surgery at the Affiliated Tumor Hospital of Shandong First Medical University from 2014 to 2018. Tissue microarrays encompassing IM and TC regions were prepared and subjected to multicolor immunofluorescence staining (CK/CD8/CD103/DAPI). Image processing and phenotype recognition (CD8+ T cells, CK-CD8+; CD8+ Tbys, CK-CD8+CD103-) were performed using inFrom software, and automatic quantitative cell density analysis was conducted using R language. Differences in CD8+ T and CD8+ Tbys densities at IM and TC were analyzed using the Mann-Whitney U test. The relationship between CD8+ T, CD8+ Tbys and clinicopathological features was examined using the Kruskal-Wallis H test. The impact of CD8+ T and CD8+ Tbys on recurrence-free survival (RFS) was evaluated using Kaplan-Meier, log-rank, and Cox proportional hazards models. Results: A total of 173 patients with stage ⅠA-ⅡA NSCLC were included, with a recurrence rate of 26.6% (46/173) and a median RFS of 62.3 months (range: 44.7-71.9 months). CD8+ T and CD8+ Tbys densities (1/1 000) were significantly higher in the IM region than in the TC region [70(32, 155) vs. 37(18, 88), P<0.001; 25(11, 46) vs. 18(7, 34), P=0.002]. No significant association was found between CD8+ T, CD8+ Tbys and age, gender, smoking history, histological type, or pathological stage (all P>0.05). Patients with low-density IM CD8+ T cells had lower RFS compared to those with high-density IM CD8+ T cells (P=0.021; median RFS not reached), Further analysis revealed that patients with low-density IM CD8+ Tbys cell had lower RFS compared to those with high-density IM CD8+ Tbys (P=0.047; median RFS not reached), and low-density IM CD8+ T cell was an independent risk factor for postoperative recurrence (HR=1.836, 95% CI:1.007-3.347, P=0.048). Joint analysis of IM and TC revealed that patients with low IM CD8+ Tbys and high TC CD8+ Tbys had significantly lower RFS compared to the other three groups (P=0.006), and this combination was an independent risk factor for postoperative recurrence in early-stage NSCLC (HR=2.090, 95% CI:1.162-3.760, P=0.014). Conclusions: The spatial distribution of bystander CD8+ T cells within the primary tumor influences the prognosis of patients with early-stage NSCLC. Patients with low-density IM CD8+ Tbys and high-density TC CD8+ Tbys are more prone to recurrence after radical surgery. 目的: 探讨非小细胞肺癌(NSCLC)肿瘤微环境内旁观者CD8+ T细胞(CD8+ Tbys)在侵袭边缘(IM)和肿瘤中心(TC)的浸润差异以及对早期NSCLC预后的影响。 方法: 回顾性收集2014—2018年在山东第一医科大学附属肿瘤医院接受根治性手术的173例原发性早期NSCLC患者的术后标本。制备包含IM和TC区域的组织微阵列并进行多色免疫荧光染色(CK/CD8/CD103/DAPI),使用inFrom软件进行图像处理和表型识别(CD8+ T、CK-CD8+、CD8+ Tbys、CK-CD8+CD103-)。R语言自动定量细胞千分密度。Mann-Whitney U检验分析CD8+ T、CD8+ Tbys 在IM和TC的差异,Kruskal-Wallis检验分析CD8+ T、CD8+ Tbys和临床病理特征的关系,Kaplan-Meier、Log rank和Cox比例风险模型评估CD8+ T、CD8+ Tbys对无复发生存时间(RFS)的影响。 结果: 共纳入173例ⅠA~ⅡA期NSCLC患者,中位随访67.8个月(58.4~79.4个月),复发率为26.6%(46/173),中位RFS为62.3个月(44.7~71.9个月)。早期NSCLC IM区域中CD8+ T、CD8+ Tbys的密度(每1 000个细胞)高于TC,差异有统计学意义[70(32,155)个和37(18,88)个,P<0.001;25(11,46)个和18(7,34)个,P=0.002]。无论在IM区域还是TC区域,CD8+ T、CD8+ Tbys与年龄、性别、吸烟史、组织学类型及病理分期均无关(均P>0.05)。IM CD8+ T低密度组较IM CD8+ T高密度组的RFS更低(中位RFS均未达到,P=0.021);IM CD8+ Tbys低密度组较CD8+ Tbys高密度组的RFS更低(中位RFS均未达到,P=0.047)。IM CD8+ T低密度为术后复发独立危险因子(HR=1.836,95% CI:1.007~3.347,P=0.048)。IM和TC联合分析显示,与其他3组(高IM CD8+ Tbys伴高TC CD8+ Tbys组、高IM CD8+ Tbys伴低TC CD8+ Tbys组、低IM CD8+ Tbys伴低TC CD8+ Tbys组)比较,IM CD8+ Tbys低密度伴TC CD8+ Tbys高密度组患者的RFS显著降低(P=0.006),且为早期NSCLC术后复发的独立风险因素(HR=2.090,95% CI:1.162~3.760,P=0.014)。 结论: CD8+ Tbys在原发灶的空间分布影响早期NSCLC患者预后,IM CD8+ Tbys低密度伴TC CD8+ Tbys高密度的患者根治术后易复发。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Yang H, Yang LY, Zhao MQ, et al. [Joint analysis of invasive margins and tumor center to evaluate the prognostic value of bystander CD8+ T cells in early-stage non-small cell lung cancer]. Zhonghua Zhong Liu Za Zhi. 2025. PMID: 40534266. doi:10.3760/cma.j.cn112152-20240805-00326

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。